Inventiva (IVEVF) Total Liabilities (2018 - 2025)
Inventiva (IVEVF) posted Total Liabilities of $323.6 million for Q4 2025, up 52.19% on a QoQ basis from $212.7 million in Q2 2025, and up 34.24% year-over-year from $241.1 million in Q4 2024.
Analysis
Inventiva (IVEVF) Total Liabilities (2018 - 2025) Analysis & Trends
Inventiva has reported Total Liabilities for 8 years, with the latest figure at $323.6 million in Q4 2025.
- On a quarterly basis, Total Liabilities rose 34.24% year-over-year to $323.6 million in Q4 2025; TTM through Dec 2025 was $323.6 million, a 34.24% increase from a year earlier, with the FY2025 full-year figure at $323.6 million, up 34.24% from the prior year.
- Total Liabilities was $323.6 million for Q4 2025 at Inventiva, up from $212.7 million in the prior quarter.
- The five-year high for Total Liabilities was $323.6 million in Q4 2025, with the low at $26.1 million in Q2 2021.
- Average Total Liabilities over 5 years is $116.5 million, with a median of $78.6 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2023: Total Liabilities advanced 15.56% in 2021, then jumped 124.52% in 2023.
- Over 5 years, Total Liabilities stood at $37.9 million in 2021, then surged by 89.92% to $72.0 million in 2022, then jumped by 51.91% to $109.3 million in 2023, then surged by 120.56% to $241.1 million in 2024, then surged by 34.24% to $323.6 million in 2025.
- The last three Total Liabilities figures came in at $323.6 million (Q4 2025), $212.7 million (Q2 2025), and $241.1 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | 69.15 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | 1.72 Bn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1.53 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 819.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 323.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 323.64 Mn |
| Jun 30, 2025 | 212.65 Mn |
| Dec 31, 2024 | 241.09 Mn |
| Jun 30, 2024 | 118.46 Mn |
| Dec 31, 2023 | 109.31 Mn |
| Jun 30, 2023 | 78.57 Mn |
| Dec 31, 2022 | 71.96 Mn |
| Jun 30, 2022 | 35.00 Mn |
| Dec 31, 2021 | 37.89 Mn |
| Jun 30, 2021 | 26.14 Mn |
| Mar 31, 2021 | 27.04 Mn |
| Dec 31, 2020 | 24.06 Mn |
| Jun 30, 2020 | 22.62 Mn |
| Dec 31, 2019 | 10.62 Mn |
| Dec 31, 2018 | 20.79 Mn |